Actemra actpen 162 MG/0.9 ML 0.9ML
Ended Awarded
- Contract number
- SPE2DB25FAZW0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,144
Award facts
- Contract value 100% obligated
- $34,144.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $34,144.43 with a firm fixed price arrangement, awards AmerisourceBergen Drug Corp the supply of Actemra ActPen (162 mg/0.9 mL) for the Defense Logistics Agency (DLA). The contract represents a non-set-aside competitive award with an ultimate completion date of June 23, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Actemra is a biologic immunosuppressant medication used in the treatment of rheumatoid arthritis and other inflammatory conditions, making this delivery order part of the federal government's ongoing pharmaceutical procurement for military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including specialty medications, vaccines, and medical supplies across multiple therapeutic domains. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp competes successfully in the open market for federal medical procurement needs serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FAZW0?
SPE2DB25FAZW0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 20, 2025.
How much is contract SPE2DB25FAZW0 worth?
The government has obligated $34,144 on SPE2DB25FAZW0.
Is contract SPE2DB25FAZW0 an order under another contract?
Yes. SPE2DB25FAZW0 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FAZW0 competed?
The extent of competition for SPE2DB25FAZW0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award